10,923
Total Claims
$1.3M
Drug Cost
969
Beneficiaries
$1,363
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-11%
Cost per patient vs peers
$1,363 vs $1,524 avg
+5%
Brand preference vs peers
14.4% vs 13.7% avg
Brand vs Generic
86% generic
Brand: 1,569 claims · $1.1M
Generic: 9,354 claims · $225K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 574 | $427K |
| Rivaroxaban | 433 | $326K |
| Sacubitril/Valsartan | 237 | $245K |
| Ranolazine | 752 | $76K |
| Ticagrelor | 88 | $48K |
| Evolocumab | 41 | $29K |
| Midodrine Hcl | 177 | $18K |
| Potassium Chloride | 477 | $13K |
| Diltiazem Hcl | 420 | $11K |
| Terazosin Hcl | 569 | $11K |
| Metoprolol Succinate | 921 | $10K |
| Torsemide | 427 | $9,155 |
| Carvedilol | 982 | $8,007 |
| Atorvastatin Calcium | 805 | $7,771 |
| Clopidogrel Bisulfate | 584 | $7,121 |
Prescribing Profile
48
Unique Drugs
$998K
Patient Profile
72
Avg Age
58%
Female
1.91
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data